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SurgicalSolutions
First U.S. Patient Enrolls in
Groundbreaking Clinical Trial at Jefferson

When James Blassingame, 79, and his
wife returned home from church one
Sunday, he bent down and could not
stand back up, doubled over in pain.
He was rushed to a local hospital,
where Joseph Lombardi, MD, director
of the new Jefferson Aortic Center and
Associate Professor of Surgery was
called for consultation. Dr. Lombardi
diagnosed Mr. Blassingame with a
Type B dissection of his thoracic aorta.
Mr. Blassingame was transferred to the
Thomas Jefferson University Hospital for
surgery where he became the first patient
in the U.S. to enroll in the STABLE™
Aortic Dissection clinical trial. “The
STABLE trial is an important milestone
in the development of novel, minimally
invasive treatments for thoracic aortic
dissections,” explains Dr. Lombardi,
who is global Principal Investigator (PI)
of the study.

The STABLE™ trial is
an important milestone
in the development of
novel, minimally invasive
treatments for thoracic
aortic dissections
Mr. Blassingame, a retired staffing
specialist for the federal government,
is grandfather to 18 grandchildren and
seven great grandchildren. “At my age,
I was concerned about having any kind
of surgery,” he recalls. “I thought I could
just do without it, especially knowing
that open surgery could be fatal. But

Mr. James Blassingame, the first patient in the U.S. to enroll in the STABLE™ Aortic Dissection
clinical trial, contemplates the morning from his front porch several months after his operation.

my daughter, who is a licensed nurse
practitioner, explained how important
and non-invasive this surgery was,
and how it would really help to reduce
the risks of complications or worse.”
Performing Mr. Blassingame’s surgery
with Dr. Lombardi was Robert A.
Larson, MD, Assistant Professor of
Surgery, who serves as the site PI for
the STABLE™ trial. This trial and other
new programs at Jefferson led to the
expansion and renaming of the Division
of Vascular and Endovascular Surgery.
Endovascular surgery directs therapy
through catheters and wires placed
within the blood vessels. The stents hold
open the wall of the weakened vessel,
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and the endovascular grafts – fabric
tubes used to make a new path for the
blood to flow – are placed inside the
vessel. This minimally invasive method
spares patients the trauma and risk of
open surgery, decreases recovery time,
and improves quality of life following
the procedure.
“The STABLE™ trial will significantly
help treat a condition that affects tens of
thousands of people just like James every
year,” says Dr. Lombardi. “This truly is a
remarkable, lifesaving advancement.”
For more information about
endovascular surgery visit:
www.jeffersonhospital.org/aortic
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The Surgeons Speak

James Blassingame was a perfect
candidate for participation in the
STABLE™ Aortic Dissection clinical
trial. Given the combination of his
age, medical history, and what we
were able to learn from our pre-surgical
vascular mapping, we knew that we
could successfully treat him with the
Cook Zenith™ Dissection Endovascular
System. The technology we now have
enables us to treat patients like James
in a way that radically reduces risks and
decreases the recovery period.
In Mr. Blassingame’s case, our threedimensional TeraRecon workstation
was critical in determining if he was
anatomically suitable for endovascular
surgery. We used the 3D imaging to
measure the size of the vessel and to
determine how much to treat. It is the
ultimate planning tool—enabling you
to visualize the procedure, select the
right devices, and see in advance exactly
where the weakened vessel begins and
ends. Once planned, the operation
was performed with state of the art
equipment in our new endovascular
operating suite.
Joseph V. Lombardi, MD, (shown left)

and Robert A. Larson, MD
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Clinical Integration

Overview

Charles J. Yeo, MD
Samuel D. Gross Professor and
Chair, Department of Surgery

This fall, as we welcome new PGY1
residents and a host of new faculty
members, there is great excitement here
in the Department of Surgery.
On the clinical front, we have gained
additional work at the Methodist Hospital,
have grown the Heart Transplant and
Advanced Heart Failure Program, have seen
an upswing in liver transplants, and are now
the busiest hospital by surgical volume for
pancreas resections in the tri-state area!
On the quality front, Dr. Herbert Cohn and
Randi Altmark, RN, BSN, CNOR have done
a tremendous job with the National Surgical
Quality Improvement Program. Using those
data we have organized the Surgical Care
Committee and new Surgical Care Bundle
and are driving changes in practice, and
hopefully, better outcomes.
On the research front, our grant submissions
have doubled in the last three years.
Total grant awards for the last fiscal year
approached $2 million. We have completed
a large prospective randomized trial looking
at pancreaticojejunostomy following the
Whipple procedure, and have clinical trials
open in the Divisions of Vascular, Cardiac,
Transplant and General Surgery.
On the education front, Dr. Karen Chojnacki
has done a great job retooling our surgical
curriculum with the help of Drs. Niels
Martin and Vincent Armenti, and the
Chief Residents.
Finally, we thank Lara Allan Goldstein for her
work in greatly increasing the department’s
development dollars – most recently
accepting a generous gift from the Nicoletti
family to support an endowed professorship
in transplant surgery.

https://jdc.jefferson.edu/jss/vol3/iss2/10

Genetic Counselor Sarah Charles, MS, CGC of the Jefferson Kimmel Cancer Center Network
(JKCCN) educates families about their risk of developing an inherited disorder.

Jefferson Pancreas Tumor
Registry Opens for Enrollment
The Jefferson Pancreas Tumor Registry
(Jeff PTR) has been approved by the
Institutional Review Board of Thomas
Jefferson University Hospital and is
designed to help determine the links
between familial genetic variations,
environmental and occupational
influences, and the development of
pancreatic cancer
According to Principal Investigator,
Dr. Charles J. Yeo, “The purpose of the
Jeff PTR is to determine whether
pancreas cancer occurs more frequently
in families with a history of the disease,
and to determine the environmental and
occupational risk factors to which
pancreas cancer patients have been
exposed.” Participants will complete a

The goal is to diagnose
pancreatic cancer early when
it is easier to treat.
detailed questionnaire and may be asked
to submit a blood sample and/or cheek
swab. The questionnaire is designed to
elicit the family health history of a
patient with pancreas cancer or a nonaffected family member, and to
document exposure to occupational and
environmental factors, such as residential
radon, asbestos, and second-hand

tobacco smoke. The Jeff PTR is a
longitudinal study in which participants
may engage in long-term follow-up and
receive information regarding scientific
and epidemiological breakthroughs in
pancreas cancer.
Research has shown that certain rare
genetic conditions are associated with an
increased risk of pancreatic cancer,
including familial breast-ovarian cancer,
familial melanoma, familial colon cancer,
hereditary pancreatitis, and Peutz-Jegher’s

syndrome. Genetic Counselor Sarah
Charles, MS, CGC of the Jefferson
Kimmel Cancer Center Network
(JKCCN) educates families about their
risk of developing an inherited disorder.
Ms. Charles explains, “We haven’t yet
identified a causative gene to allow
predictive testing for pancreatic cancer.
But, for patients with a strong family
history of pancreatic cancer, we can offer
risk assessments and possibly surveillance
with endoscopic ultrasound.”
Such high risk patients may be
referred to Jefferson gastroenterologists
such as Thomas Kowalski, MD and
David Loren, MD to discuss the pros and
cons of invasive surveillence. The goal is
to diagnose pancreatic cancer early when
it is easier to treat. For persons who do
develop pancreatic cancer, Jefferson
physicians may use the results of genetic
testing to select the most effective
therapy. Targeted therapy for pancreas
cancer is becoming a reality in part due
to recent discoveries made in the
laboratory of Jonathan Brody, PhD,
Assistant Professor of Surgery, where
molecular studies have clearly indicated
survival advantages with the use of
targeted chemotherapy treatment.
For more information about the Jefferson
Pancreas Tumor Registry please visit
www.jeffersonhospital.org/pancreasregistry

Please Welcome

Meet Our
Surgical Interns
Jefferson surgeons are
currently assisted by
an exceptional group of
categorical interns, half of
them Jefferson Medical
College graduates. These
doctors, who recently
matched with Jefferson,
started on June 20, 2008 (l to r):
Danielle Pineda, MD, Jefferson Medical
College; Richard Burkhart, MD, Boston
University School of Medicine;
Aleksandra Policha, MD, SUNY/Syracuse;
Daniel Relles, MD, Jefferson Medical College;
Christina Khan, MD, PhD, University of Illinois;

and Jason Walls, MD, Jefferson
Medical College
We are also pleased to welcome back
two additional Jefferson Medical College
graduates, Carrie Houssock, MD, and Jordan
Goldhammer, MD, as preliminary interns in
General Surgery.
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Changing Lives Through Research

On the Job

Tanya Wynder,
MSN, CRNP, NP-C

Tanya Wynder is one of two
Transplant Surgery Nurse Practitioners in the Department of Surgery.
She came to Jefferson in April 2006
from Temple University Hospital.
Can you describe your role as a
Transplant Nurse Practitioner?

I am deeply involved in patients’
pre- and post-operative care,
including patient assessment, history,
and physicals. I provide direct care
immediately after surgery for patients
at the hospital as well as outpatients
at the clinic. In 2007, we transplanted
63 livers, 47 kidneys, and 3
pancreases at Jefferson.
Stephen McIlhenny, PhD candidate with Drs. Eric Hager and Neil Moudgill.

Surgical Residents and PhD
Candidate Make Significant
Contributions to Ongoing Adult
Stem Cell Research
Paul DiMuzio, MD, directs the Vascular
Tissue Engineering Laboratory within
the Department of Surgery at Thomas
Jefferson University. “The overall goal
of our research is to develop a durable
blood vessel replacement for those
patients who do not have enough of their
own tissues for heart or leg bypass surgery
or hemodialysis access. We combine
tissue engineering techniques with adult
stem cell technology to make such a
graft,” explains Dr. DiMuzio. Specifically,
the researchers repopulate a cadaver
blood vessel with the patient’s own stem
cells (isolated from their fat) that have
been changed into endothelial cells.

investigated these issues under the
mentorship of Dr. DiMuzio:

Recent work has focused on the effects
of fluid-induced shear stress and genetic
manipulation on the differentiation
of the stem cells. The investigators are
developing methods to more effectively
change the stem cells into endothelial
cells by altering their environment
as well as their genetic composition.
The following research trainees have

shear stress improves the ability of stem
cells to adhere to grafts secondary to
up-regulation of integrin expression
(proteins on the cell surface necessary for
cell adhesion). Dr. Hager presented this
work at the Society of Vascular Surgery’s
National Annual meeting in June, 2008
in San Diego—a presentation highlighted
in a press release at the meeting.

Published by Jefferson Digital Commons, 2008

During his research year, Eric Hager,
MD, a 4th year resident, studied
how fluid flow influences stem cell
adhesion to the vascular graft. Dr.
Hager successfully demonstrated that

The overall goal of our
research is to develop
a durable blood vessel
replacement for those
patients who do not have
enough of their
own tissues.

year that they get back. Imagine what
you would do with an extra 600 hours
a year!

What’s the best part of your job?

Well, there are really two things.
First are the people I work with.
Here, nurse practitioners are truly
valued and have an important role.
That goes a long way in my job
satisfaction. Second is getting to
know pre-transplant patients and
then to see the real transformation
the surgery brings to their lives. For
example, kidney recipients no longer
need dialysis 4 hours a day for 3 days
a week—that’s more than 600 hours a

Neil Moudgill, MD, another 4th year
resident, evaluated the role of shear
stress on stem cell differentiation. He
found that shear stress significantly
up-regulated certain endothelial cellspecific proteins due to stimulation of a
specific differentiating pathway. His work
was presented at the Annual Resident
Research Competition at the University
of Rochester in April, 2008. Neil’s
presentation was picked as one of three
winners in this national competition.
While surgical residents spend one year
in the research laboratory, Stephen
McIlhenny, BS, is currently in his fourth
year as a PhD candidate in Jefferson’s
Tissue Engineering and Regenerative
Medicine (T.E.R.M.) program. Stephen
designed a novel vascular bioreactor
in which the stem cell vascular graft is
created and cultured. He successfully
demonstrated that a gradual increase in
shear stress was critical to the retention

How did you become interested in
transplant surgery?

When I was younger, my father
needed a heart transplant. He wasn’t
patient. One day he said “enough”—
he left the hospital and died the next
day at home. While I am first and
foremost a professional, I think with
that experience I bring another layer
of compassion and understanding to
my patients and their families.

of stem cells on the graft, work that
he presented at the 2007 Biomedical
Engineering Society (BMES) Annual
Meeting in Los Angeles.
Additionally, Stephen recently genetically
manipulated the stem cells to express
endothelial nitric oxide synthase (eNOS),
a gene critical for function of endothelial
cells. Most importantly, Steven
demonstrated that this manipulation has
led to the release nitric oxide (NO), a
molecule critical to blood vessel function
and health. Steven’s research on stem cell
eNOS transfection will be presented at
the Tissue Engineering and Regenerative
Medicine International Society
(TERMIS) meeting in December 2008.
Under the sponsorship of Thomas
Tulenko, PhD, Director of the Division
of Research, and Dr. DiMuzio, Stephen
has been granted an American Heart
Association Pre-doctoral Fellowship.

For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
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News in Brief

Those Who Give

The Nicoletti Family
Professorship in
Transplantation
Surgery

Kristin Brill, MD has joined the

Robert and Beatrice Nicoletti
and their family have generously
established an endowed
professorship in honor of Cataldo
Doria, MD, PhD, FACS, Associate
Professor of Surgery and Director
of the Division of Transplantation
Surgery.
“Dr. Doria literally saved my
life,” says Robert Nicoletti. “And
everyone at Jefferson was so
caring, thoughtful and
encouraging. I now have a new
lease on life.”
For four years, Robert’s kidneys
were progressively failing him –
the result of hypertension, or high
blood pressure. Robert initially
concealed his worsening
condition from his close knit
family. In early 2006, however,
the team at Jefferson determined
that he needed a transplant and
Robert told his family.
Seven members of the Nicoletti
family immediately volunteered
to donate a kidney. Ultimately,
only one family member was
deemed compatible: Robert’s
daughter, Lori Peruto. She recalls,
“When we learned of Dad’s
condition, we knew what we had

Michel Haddad, MD has joined the
Department of Surgery’s Division of
Kristin Brill, MD
Cardiothoracic Surgery. He specializes in
ventricular assist devices, minimally invasive and minimal access
cardiac surgery, and cardiac ICU care.

Department of Surgery’s Division of
General Surgery after seven years as a
volunteer faculty member in private
practice. She specializes in breast surgery.

Cataldo Doria, MD, PhD, FACS with Robert and Beatrice Nicoletti, and
their daughter Lori Peruto

to do. There was no question, no
hesitation.”
On June 6, 2006, Robert and
Lori arrived at Jefferson for the
life-changing procedure. Beatrice
Nicoletti was truly impressed
with her family’s experience at
Jefferson. “When something like
this happens, you’re scared,” she
says, “but the staff at Jefferson kept
us informed every step of the way.
That helped ease our fears.”
Robert and Lori quickly regained
their strength and returned to their
normal lifestyle in a few weeks.
Both remain in good health, which
they attribute to Dr. Doria and the
multidisciplinary team at Jefferson.
“We knew we were in good
hands,” Beatrice says.
Endowed professorships such
as this are a critical resource to
recruit and retain a distinguished

SurgicalSolutions
Jefferson Department of Surgery
620 Curtis Building
1015 Walnut Street
Philadelphia, PA 19107
www.JeffersonHospital.org/surgery

faculty, and they provide distinct
honor and recognition for the
faculty members who hold them.
“This provides a reliable source
of funding as we seek to expand
our growing transplant program
here at Jefferson,” says Dr. Doria.
“We are all extremely grateful to
the Nicoletti family for their
generous gift.”
Jefferson’s Eakins Legacy Fund
will match this gift dollar-fordollar. The Fund was created from
the proceeds of the sale of Thomas
Eakins’s The Gross Clinic to
support the institution’s key
initiatives.
For additional information on the

Jay Jenoff, MD and Niels Martin, MD have joined the Department
of Surgery’s Division of Acute Care Surgery. Both surgeons recently
completed a Fellowship in Traumatology & Surgical Critical Care
at the Hospital of the University of Pennsylvania. Dr. Jenoff is a
2005 graduate of the Deparment’s residency program. Dr. Martin,
a 2006 graduate of the residency program, has also been named the
Associate Program Director.
Harish Lavu, MD has joined the Department of Surgery’s

Division of General Surgery. He recently completed a Fellowship
in Hepatobiliary and Pancreatic Surgery at the Indiana School of
Medicine in Indianapolis.
John Pinckney Maxwell IV, MD recenty completed his Fellowship

in Colon and Rectal Surgery at Thomas Jefferson University Hospital
and has joined the Department of Surgery’s Division of Colon and
Rectal Surgery.
Benny Weksler, MD, MBA, has joined the Department of Surgery’s

Division of Cardiothoracic Surgery. He recently completed a
fellowship in minimally invasive surgery at the University of
Pittsburgh Medical Center after several years in private practice in
Brazil. He specializes in thoracic surgical oncology.
Gerald Isenberg, MD was named the President of the Association of
Program Directors for Colorectal Surgery.

contact Lara Allan Goldstein, Director

Save the Date: November 1, 2008
Third Annual Pancreatic Cancer Patient Symposium
Registration required. For more information, go to

of Development, at 215-955-8797.

www.jeffersonhospital.org/pancreas

Eakins Legacy Fund and ways to support
the Department of Surgery, please

620 Curtis Building
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